UBS MSCI Switzerland 20/35 UCITS ETF hUSD dis

What this fund is

UBS MSCI Switzerland 20/35 UCITS ETF hUSD dis is an exchange-traded fund (ETF) from UBS, traded under the ticker 0A5M (ISIN LU1169830285). It lets you buy a basket of holdings in a single trade, spreading your money across them rather than one company. In plain terms it is about owning small slices of companies, so you share in their growth when they do well — and their falls when they don't, focused on the European market. Rather than a manager picking stocks, it simply replicates the MSCI Switzerland 20/35 index — the passive, low-cost approach, and its largest holdings include ROCHE HLDG PC PRP, NOVARTIS AG-REG and NESTLE SA-REG. Geographically it leans ~75.8% Switzerland.

By industry it concentrates most in ~30.9% Health Care and ~15.6% Financials. Funds like this are commonly chosen by investors who want a regular cash income stream rather than reinvesting everything for growth. Its ongoing charge (TER) is 0.23% a year — about €23 a year on a €10,000 holding, taken automatically from the fund. Income such as dividends is paid out to you as cash (a distributing share class), and over the last year it paid out roughly 2.7% (its trailing yield). It holds the underlying investments directly (physical replication); it is domiciled in Luxembourg and UCITS-regulated, a European standard built to protect everyday investors and trades in USD.

Its price has swung about 11.5% over the past year, which describes how much its price tends to move rather than whether it is good. It launched in 2020. As with any investment, its value can go down as well as up, and past performance is not a guide to future results. (Fund data sourced from UBS.)